Personalis at Biomarkers EU Congress – 2020: February 19-20
Presentation
Erin Newburn, MS, PhD
Associate Director, Field Application Scientist
Wednesday, February 19 | 9:00 AM
Maximizing Immunotherapy Biomarker Discovery with an Advanced Tumor Immunogenomics Platform
- The complexity of the tumor and tumor microenvironment suggests a comprehensive approach is required for accurate characterization of the broader cancer ecosystem
- The ImmunoID NeXT platform consolidates multiple biomarker assays into one with the ability to detect neoantigens, characterize the immune repertoire and identify novel biomarker signatures from a single sample
- Featuring a case study demonstrating the ability of this immunogenomics profiling platform to uncover tumor escape mechanisms
